CONGRESS

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 28 November, 2025 0

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 27 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 26 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

INTRAVASCULAR IMAGING & Angio-based Physiology guided complex LEFT MAIN BIFURCATION, SOLACI-SBHCI 23

Structural Summit 2024 – Deadline Extended: One More Week to Submit Your Work

Transcatheter Pulmonary Valve Replacement | SOLACI-SBHCI 2023 – International Live Case

PDA closure in small infant | SOLACI-SBHCI 2023 – National Live Case

Challenge VSD Closure | SOLACI-SBHCI 2023 – National Live Case

Step-by-Step Left Atrium Appendage Closure with New Generation Device | SOLACI-SBHCI 2023

A second attempt for a heavily CALCIFIED LESION | SOLACI-SBHCI 2023 – National Live Case

TAVI for Pure Aortic Valve Regurgitation Using a Newself-Expanding Technology | SOLACI-SBHCI 2023

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access